Home Page - Icthic Magazine

LATEST ARTICLES

Looking for a reliable tool to identify hypercoagulant markers for cancer risk and prognosis: the HYPERCAN study

The HYPERCAN (HYPERcoagulation in CANcer) study (registered at www.clinicaltrials.gov; NCT02622815) is an ongoing,...

Isolated Distal DVT In Cancer Patients: What Do Recent Studies Suggest?

In a recent issue of the Journal of Thrombosis and Hemostasis, we report that cancer patients with isolated distal deep...

Measurement of extracellular vesicles and their role in cancer-associated thrombosis

Extracellular vesicles (EV) are submicron vesicles released from activated cells, apoptotic cells and cancer cells...

Venous thromboembolism in patients with solid tumors: the Italian Association of Medical Oncology (AIOM) guidelines 2019

The latest guidelines for venous thromboembolism in patients with solid tumors from the Italian Association of Medical...

Direct oral anticoagulants for the treatment of cancer-associated thrombosis

Cancer-associated venous thromboembolism (VTE) is known to impact up to one-fifth of patients with cancer. The...

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

The American Society of Clinical Oncology just published the new recommendations regarding VTE prophylaxis and...

FEATURED VIDEO

ISTH 2019: The CAT treatment, from trials to clinical practice by ICTHIC Editorial Office 29 July 2019

The big Gary Raskob interview by ICTHIC Editorial Office 24 September 2018

An interview with Grigorios Gerotziafas by ICTHIC Editorial Office 11 September 2018

ISTH 2018 – Anna Falanga by ICTHIC Editorial Office 3 August 2018

None of the information published on the ICTHC magazine website, in particular, information related to the choice and use of drugs, replaces the advice of a doctor.

Accept to continue